Cargando…
Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development
BACKGROUND: mRNA vaccines are emerging as new targets for cancer immunotherapy. However, the potential tumor antigens for mRNA vaccine design in hepatocellular carcinoma (HCC) remain to be elucidated. METHODS: Genetic and RNA-Seq data were obtained from TCGA and ICGC. Tumor-specific antigens (TSAs)...
Autores principales: | Fu, Jiantao, Chen, Feng, Lin, Yuanji, Gao, Jin, Chen, Anna, Yang, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9423891/ https://www.ncbi.nlm.nih.gov/pubmed/36038676 http://dx.doi.org/10.1007/s00432-022-04325-2 |
Ejemplares similares
-
Identification of tumor antigens and immune subtypes of hepatocellular carcinoma for mRNA vaccine development
por: Lu, Tai-Liang, et al.
Publicado: (2023) -
Identifying Potential Tumor Antigens and Antigens-Related Subtypes in Hepatocellular Carcinoma for mRNA Vaccine Development
por: Liao, Weiran, et al.
Publicado: (2022) -
ATG101-related signature predicts prognosis and therapeutic option in hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2022) -
Identification of tumor-specific neoantigens and immune clusters of hepatocellular carcinoma for mRNA vaccine development
por: Li, Yi-Fei, et al.
Publicado: (2022) -
Identification of tumor antigens and immune landscapes for bladder urothelial carcinoma mRNA vaccine
por: Sun, Zhuolun, et al.
Publicado: (2023)